BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8458489)

  • 1. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism.
    Shoham Z; Mannaerts B; Insler V; Coelingh-Bennink H
    Fertil Steril; 1993 Apr; 59(4):738-42. PubMed ID: 8458489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
    J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
    Schoot DC; Harlin J; Shoham Z; Mannaerts BM; Lahlou N; Bouchard P; Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jul; 9(7):1237-42. PubMed ID: 7962424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
    Mannaerts B; Fauser B; Lahlou N; Harlin J; Shoham Z; Bennink HC; Bouchard P
    Fertil Steril; 1996 Feb; 65(2):406-10. PubMed ID: 8566271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.
    Mannaerts B; Shoham Z; Schoot D; Bouchard P; Harlin J; Fauser B; Jacobs H; Rombout F; Coelingh Bennink H
    Fertil Steril; 1993 Jan; 59(1):108-14. PubMed ID: 8419196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
    Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
    van Heusden AM; Coelingh Bennink HJ; Fauser BC
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
    Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
    J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.
    Voortman G; Mannaerts BM; Huisman JA
    Fertil Steril; 2000 Jun; 73(6):1187-93. PubMed ID: 10856481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.
    Duijkers IJ; Klipping C; Boerrigter PJ; Machielsen CS; De Bie JJ; Voortman G
    Hum Reprod; 2002 Aug; 17(8):1987-93. PubMed ID: 12151425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect.
    O'Dea L; O'Brien F; Currie K; Hemsey G
    Curr Med Res Opin; 2008 Oct; 24(10):2785-93. PubMed ID: 18727841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.
    Matsumoto K; Imakawa K; Hayashi C
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):312. PubMed ID: 28931393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: a nonrandomized controlled pilot study.
    Awwad JT; Farra C; Mitri F; Abdallah MA; Jaoudeh MA; Ghazeeri G
    Reprod Biomed Online; 2013 Jan; 26(1):88-92. PubMed ID: 23177418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.